In cancer, STAT3 is involved in a complex network of signaling pathways (including NF-κB and IL-6) and alternative splicing events, resulting in the production of two isoforms: STAT3α and STAT3β [10,16,20,21]. This evidence concerns the gene IL6 and cancer.